Mechanistic links between COPD and lung cancer (original) (raw)
Peto, R., Chen, Z. M. & Boreham, J. Tobacco-the growing epidemic. Nature Med.5, 15–17 (1999). ArticleCASPubMed Google Scholar
Youlden, D. R., Cramb, S. M. & Baade, P. D. The International Epidemiology of Lung Cancer: geographical distribution and secular trends. J. Thorac. Oncol.3, 819–831 (2008). ArticlePubMed Google Scholar
Wasswa-Kintu, S., Gan, W. Q., Man, S. F., Pare, P. D. & Sin, D. D. Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Thorax60, 570–575 (2005). ArticleCASPubMedPubMed Central Google Scholar
Skillrud, D. M., Offord, K. P. & Miller, R. D. Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study. Ann. Intern. Med.105, 503–507 (1986). The first study to show increased lung cancer incidence in patients with COPD. ArticleCASPubMed Google Scholar
Tockman, M. S., Anthonisen, N. R., Wright, E. C. & Donithan, M. G. Airways obstruction and the risk for lung cancer. Ann. Intern. Med.106, 512–518 (1987). ArticleCASPubMed Google Scholar
Lange, P., Nyboe, J., Appleyard, M., Jensen, G. & Schnohr, P. Ventilatory function and chronic mucus hypersecretion as predictors of death from lung cancer. Am. Rev. Respir. Dis.141, 613–617 (1990). ArticleCASPubMed Google Scholar
Speizer, F. E., Fay, M. E., Dockery, D. W. & Ferris, B. G. Jr. Chronic obstructive pulmonary disease mortality in six U.S. cities. Am. Rev. Respir. Dis.140, S49–S55 (1989). ArticleCASPubMed Google Scholar
Sin, D. D., Anthonisen, N. R., Soriano, J. B. & Agusti, A. G. Mortality in COPD: role of comorbidities. Eur. Respir. J.28, 1245–1257 (2006). ArticleCASPubMed Google Scholar
Young, R. P. et al. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur. Respir. J.34, 380–386 (2009). ArticleCASPubMed Google Scholar
Pauwels, R. A., Buist, A. S., Calverley, P. M., Jenkins, C. R. & Hurd, S. S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am. J. Respir. Crit. Care Med.163, 1256–1276 (2001). ArticleCASPubMed Google Scholar
Shapiro, S. D. & Ingenito, E. P. The pathogenesis of chronic obstructive pulmonary disease: advances in the past 100 years. Am. J. Respir. Cell. Mol. Biol.32, 367–372 (2005). ArticleCASPubMed Google Scholar
Mannino, D. M. Epidemiology and global impact of chronic obstructive pulmonary disease. Semin. Respir. Crit. Care Med.26, 204–210 (2005). ArticlePubMed Google Scholar
Travis, W. D. et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary. Proc. Am. Thorac. Soc.8, 381–385 (2011). ArticlePubMed Google Scholar
Sun, S., Schiller, J. H. & Gazdar, A. F. Lung cancer in never smokers--a different disease. Nature Rev. Cancer7, 778–790 (2007). ArticleCAS Google Scholar
Punturieri, A., Szabo, E., Croxton, T. L., Shapiro, S. D. & Dubinett, S. M. Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research. J. Natl Cancer Inst.101, 554–559 (2009). ArticlePubMedPubMed Central Google Scholar
Wilson, D. O. et al. Association of radiographic emphysema and airflow obstruction with lung cancer. Am. J. Respir. Crit. Care Med.178, 738–744 (2008). Definitive study showing that the presence of radiographic emphysema confers lung cancer risk. ArticlePubMedPubMed Central Google Scholar
Ueda, K. et al. Computed tomography-diagnosed emphysema, not airway obstruction, is associated with the prognostic outcome of early-stage lung cancer. Clin. Cancer Res.12, 6730–6736 (2006). ArticlePubMed Google Scholar
de Torres, J. P. et al. Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest132, 1932–1938 (2007). ArticlePubMed Google Scholar
Li, Y. et al. Effect of emphysema on lung cancer risk in smokers: a computed tomography-based assessment. Cancer Prev. Res.4, 43–50 (2011). Article Google Scholar
Zulueta, J. J. et al. Emphysema scores predict death from COPD and lung cancer. Chest141, 1216–1223 (2012). ArticlePubMed Google Scholar
Wilson, D. O. et al. Quantitative computed tomography analysis, airflow obstruction, and lung cancer in the pittsburgh lung screening study. J. Thorac. Oncol.6, 1200–1205 (2011). ArticlePubMedPubMed Central Google Scholar
Maldonado, F. et al. Are airflow obstruction and radiographic evidence of emphysema risk factors for lung cancer? A nested case-control study using quantitative emphysema analysis. Chest138, 1295–1302 (2010). ArticlePubMed Google Scholar
Berk, D. R., Bentley, D. D., Bayliss, S. J., Lind, A. & Urban, Z. Cutis laxa: a review. J. Am. Acad. Dermatol.66, 842.e1–842.e17 (2012). Article Google Scholar
Brantly, M., Nukiwa, T. & Crystal, R. G. Molecular basis of α-1-antitrypsin deficiency. Am. J. Med.84, 13–31 (1988). ArticlePubMed Google Scholar
Shapiro, S. D., Endicott, S. K., Province, M. A., Pierce, J. A. & Campbell, E. J. Marked longevity of human lung parenchymal elastic fibers deduced from prevalence of D-aspartate and nuclear weapons-related radiocarbon. J. Clin. Invest.87, 1828–1834 (1991). ArticleCASPubMedPubMed Central Google Scholar
Heidelberger, K. P. α-1-antitrypsin deficiency: a review; 1963–1975. Ann. Clin. Lab Sci.6, 110–117 (1976). CASPubMed Google Scholar
Shapiro, S. D. The pathogenesis of emphysema: the elastase:antielastase hypothesis 30 years later. Proc. Assoc. Am. Physicians107, 346–352 (1995). CASPubMed Google Scholar
Gross, P., Pfitzer, E. A., Tolker, E., Babyak, M. A. & Kaschak, M. Experimental emphysema: its production with papain in normal and silicotic rats. Arch. Environ. Health11, 50–58 (1965). ArticleCASPubMed Google Scholar
Larsson, C. Natural history and life expectancy in severe α1-antitrypsin deficiency, Pi Z. Acta Med. Scand.204, 345–351 (1978). ArticleCASPubMed Google Scholar
Yang, P. et al. α1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk. Arch. Intern. Med.168, 1097–1103 (2008). ArticlePubMedPubMed Central Google Scholar
Yang, P. et al. α1-antitrypsin and neutrophil elastase imbalance and lung cancer risk. Chest128, 445–452 (2005). ArticleCASPubMed Google Scholar
Petrache, I. et al. A novel antiapoptotic role for α1-antitrypsin in the prevention of pulmonary emphysema. Am. J. Respir. Crit. Care Med.173, 1222–1228 (2006). ArticleCASPubMedPubMed Central Google Scholar
Demeo, D. L. et al. The SERPINE2 gene is associated with chronic obstructive pulmonary disease. Am. J. Hum. Genet.78, 253–264 (2006). ArticleCASPubMed Google Scholar
Cho, M. H. et al. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nature Genet.42, 200–202 (2010). ArticleCASPubMed Google Scholar
Pillai, S. G. et al. Loci identified by genome-wide association studies influence different disease-related phenotypes in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med.182, 1498–1505 (2010). ArticlePubMedPubMed Central Google Scholar
Thorgeirsson, T. E. et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature452, 638–642 (2008). One of the original studies linking polymorphisms inCHRNA3andCHRNA5to cigarette consumption, nicotine dependence and lung cancer. ArticleCASPubMedPubMed Central Google Scholar
Hung, R. J. et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature452, 633–637 (2008). ArticleCASPubMed Google Scholar
Amos, C. I. et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nature Genet.40, 616–622 (2008). ArticleCASPubMed Google Scholar
Belinsky, S. A. et al. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res.62, 2370–2377 (2002). CASPubMed Google Scholar
Belinsky, S. A. Silencing of genes by promoter hypermethylation: key event in rodent and human lung cancer. Carcinogenesis26, 1481–1487 (2005). ArticleCASPubMed Google Scholar
Zhang, H. T. et al. Defective expression of transforming growth factor β receptor type II is associated with CpG methylated promoter in primary non-small cell lung cancer. Clin. Cancer Res.10, 2359–2367 (2004). ArticleCASPubMed Google Scholar
Zochbauer-Muller, S. et al. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res.61, 249–255 (2001). CASPubMed Google Scholar
Ohtani-Fujita, N. et al. CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene. Oncogene8, 1063–1067 (1993). CASPubMed Google Scholar
Dammann, R., Takahashi, T. & Pfeifer, G. P. The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas. Oncogene20, 3563–3567 (2001). ArticleCASPubMed Google Scholar
Belinsky, S. A. et al. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc. Natl Acad. Sci. USA95, 11891–11896 (1998). ArticleCASPubMedPubMed Central Google Scholar
Qiu, W. et al. Variable DNA methylation is associated with chronic obstructive pulmonary disease and lung function. Am. J. Respir. Crit. Care Med.185, 373–381 (2012). ArticleCASPubMedPubMed Central Google Scholar
Kasahara, Y. et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J. Clin. Invest.106, 1311–1319 (2000). The semimal report highlighting the importance of cellular apoptosis in the pathogenesis of emphysema. ArticleCASPubMedPubMed Central Google Scholar
Aoshiba, K., Yokohori, N. & Nagai, A. Alveolar wall apoptosis causes lung destruction and emphysematous changes. Am. J. Respir. Cell. Mol. Biol.28, 555–562 (2003). ArticleCASPubMed Google Scholar
Shapiro, S. D. Vascular atrophy and VEGFR-2 signaling: old theories of pulmonary emphysema meet new data. J. Clin. Invest.106, 1309–1310 (2000). ArticleCASPubMedPubMed Central Google Scholar
Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell144, 646–674 (2011). The definitive review on the key features that define malignancy. ArticleCASPubMed Google Scholar
Steiling, K., Ryan, J., Brody, J. S. & Spira, A. The field of tissue injury in the lung and airway. Cancer Prev. Res.1, 396–403 (2008). ArticleCAS Google Scholar
Slaughter, D. P., Southwick, H. W. & Smejkal, W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer6, 963–968 (1953). ArticleCASPubMed Google Scholar
Franklin, W. A. et al. Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis. J. Clin. Invest.100, 2133–2137 (1997). ArticleCASPubMedPubMed Central Google Scholar
Chang, Y. L. et al. Clonality and prognostic implications of p53 and epidermal growth factor receptor somatic aberrations in multiple primary lung cancers. Clin. Cancer Res.13, 52–58 (2007). ArticleCASPubMed Google Scholar
Wistuba, I. I. et al. Molecular damage in the bronchial epithelium of current and former smokers. J. Natl Cancer Inst.89, 1366–1373 (1997). ArticleCASPubMed Google Scholar
Tang, X. et al. EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients. Cancer Res.65, 7568–7572 (2005). ArticleCASPubMed Google Scholar
Ji, H. et al. K-ras activation generates an inflammatory response in lung tumors. Oncogene25, 2105–2112 (2006). ArticleCASPubMed Google Scholar
Sparmann, A. & Bar-Sagi, D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell6, 447–458 (2004). This is the seminal report of RAS-induced expression of IL-8. This work confirms that cancers have the ability to manipulate host immune cell function to their benefit. ArticleCASPubMed Google Scholar
Spira, A. et al. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nature Med.13, 361–366 (2007). This study validates the concept that cells residing in the field of risk can predict the presence of distal cancers on the basis of their genetic profiles. ArticleCASPubMed Google Scholar
Gustafson, A. M. et al. Airway PI3K pathway activation is an early and reversible event in lung cancer development. Sci. Transl. Med.2, 26ra25 (2010). ArticlePubMedPubMed CentralCAS Google Scholar
Jackson, E. L. et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev.15, 3243–3248 (2001). This is the initial report of the LSL-Krasmouse that develops lung adenoma and adenocarcinoma. It is the mouse model that is most commonly used to study lung cancer. ArticleCASPubMedPubMed Central Google Scholar
Kim, C. F. et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell121, 823–835 (2005). ArticleCASPubMed Google Scholar
Yatabe, Y., Borczuk, A. C. & Powell, C. A. Do all lung adenocarcinomas follow a stepwise progression? Lung Cancer74, 7–11 (2011). ArticlePubMed Google Scholar
Karimi, R., Tornling, G., Grunewald, J., Eklund, A. & Skold, C. M. Cell recovery in bronchoalveolar lavage fluid in smokers is dependent on cumulative smoking history. PLoS ONE7, e34232 (2012). ArticleCASPubMedPubMed Central Google Scholar
Merchant, R. K., Schwartz, D. A., Helmers, R. A., Dayton, C. S. & Hunninghake, G. W. Bronchoalveolar lavage cellularity. The distribution in normal volunteers. Am. Rev. Respir. Dis.146, 448–453 (1992). ArticleCASPubMed Google Scholar
Hogg, J. C. et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med.350, 2645–2653 (2004). Definitive study characterizing the quality and quantity of airway inflammation in patients with COPD. ArticleCASPubMed Google Scholar
Grumelli, S. et al. An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med.1, e8 (2004). Seminal study providing a mechanistic basis for the role of lymphocytes in COPD pathogenesis in humans. ArticlePubMedPubMed CentralCAS Google Scholar
Shaykhiev, R. et al. Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease. J. Immunol.183, 2867–2883 (2009). ArticleCASPubMed Google Scholar
Kunz, L. I. et al. Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD. Respir. Res.12, 34 (2011). ArticleCASPubMedPubMed Central Google Scholar
Maeno, T. et al. CD8+ T Cells are required for inflammation and destruction in cigarette smoke-induced emphysema in mice. J. Immunol.178, 8090–8096 (2007). ArticleCASPubMed Google Scholar
Mio, T. et al. Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. Am. J. Respir. Crit. Care Med.155, 1770–1776 (1997). ArticleCASPubMed Google Scholar
Shan, M. et al. Lung myeloid dendritic cells coordinately induce TH1 and TH17 responses in human emphysema. Sci. Transl. Med.1, 4ra10 (2009). ArticlePubMedCAS Google Scholar
Chen, K. et al. IL-17RA is required for CCL2 expression, macrophage recruitment, and emphysema in response to cigarette smoke. PLoS ONE6, e20333 (2011). ArticleCASPubMedPubMed Central Google Scholar
de Visser, K. E., Eichten, A. & Coussens, L. M. Paradoxical roles of the immune system during cancer development. Nature Rev. Cancer6, 24–37 (2006). ArticleCAS Google Scholar
Mantovani, A., Sozzani, S., Locati, M., Allavena, P. & Sica, A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol.23, 549–555 (2002). ArticleCASPubMed Google Scholar
Gabrilovich, D. I. & Nagaraj, S. Myeloid-derived suppressor cells as regulators of the immune system. Nature Rev. Immunol.9, 162–174 (2009). ArticleCAS Google Scholar
Fridlender, Z. G. et al. Polarization of tumor-associated neutrophil phenotype by TGF-β: “N1” versus “N2” TAN. Cancer Cell16, 183–194 (2009). ArticleCASPubMedPubMed Central Google Scholar
Moghaddam, S. J. et al. Promotion of lung carcinogenesis by chronic obstructive pulmonary disease-like airway inflammation in a K-ras-induced mouse model. Am. J. Respir. Cell. Mol. Biol.40, 443–453 (2009). ArticleCASPubMed Google Scholar
Gallina, G. et al. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. J. Clin. Invest.116, 2777–2790 (2006). ArticleCASPubMedPubMed Central Google Scholar
Chen, M. L. et al. Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivo. Proc. Natl Acad. Sci. USA102, 419–424 (2005). ArticleCASPubMed Google Scholar
Whiteside, T. L. Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention. Semin. Cancer Biol.16, 3–15 (2006). ArticleCASPubMed Google Scholar
Haqqani, A. S., Sandhu, J. K. & Birnboim, H. C. Expression of interleukin-8 promotes neutrophil infiltration and genetic instability in mutatect tumors. Neoplasia2, 561–568 (2000). ArticleCASPubMedPubMed Central Google Scholar
Dinarello, C. A. The paradox of pro-inflammatory cytokines in cancer. Cancer Metastasis Rev.25, 307–313 (2006). ArticleCASPubMed Google Scholar
Takahashi, H., Ogata, H., Nishigaki, R., Broide, D. H. & Karin, M. Tobacco smoke promotes lung tumorigenesis by triggering IKKβ- and JNK1-dependent inflammation. Cancer Cell17, 89–97 (2010). ArticleCASPubMedPubMed Central Google Scholar
Zhang, J. Y., Wang, Y. & Prakash, C. Xenobiotic-metabolizing enzymes in human lung. Curr. Drug Metab.7, 939–948 (2006). ArticleCASPubMed Google Scholar
Dix, T. A. & Marnett, L. J. Metabolism of polycyclic aromatic hydrocarbon derivatives to ultimate carcinogens during lipid peroxidation. Science221, 77–79 (1983). ArticleCASPubMed Google Scholar
Feyler, A. et al. Point: myeloperoxidase −463G ⊠ a polymorphism and lung cancer risk. Cancer Epidemiol. Biomarkers Prev.11, 1550–1554 (2002). CASPubMed Google Scholar
Nguyen, T., Nioi, P. & Pickett, C. B. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J. Biol. Chem.284, 13291–13295 (2009). ArticleCASPubMedPubMed Central Google Scholar
Rangasamy, T. et al. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J. Clin. Invest.114, 1248–1259 (2004). ArticleCASPubMedPubMed Central Google Scholar
Satoh, H. et al. Nrf2-deficiency creates a responsive microenvironment for metastasis to the lung. Carcinogenesis31, 1833–1843 (2010). ArticleCASPubMed Google Scholar
Kensler, T. W. et al. Modulation of the metabolism of airborne pollutants by glucoraphanin-rich and sulforaphane-rich broccoli sprout beverages in Qidong, China. Carcinogenesis33, 101–107 (2012). ArticleCASPubMed Google Scholar
Shureiqi, I. & Baron, J. A. Curcumin chemoprevention: the long road to clinical translation. Cancer Prev. Res.4, 296–298 (2011). ArticleCAS Google Scholar
Sporn, M. B. & Liby, K. T. NRF2 and cancer: the good, the bad and the importance of context. Nature Rev. Cancer12, 564–571 (2012). ArticleCAS Google Scholar
Solis, L. M. et al. Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features. Clin. Cancer Res.16, 3743–3753 (2010). ArticleCASPubMedPubMed Central Google Scholar
Liu, Z. et al. The serpin α1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Cell102, 647–655 (2000). ArticleCASPubMed Google Scholar
Atkinson, J. J. et al. The role of matrix metalloproteinase-9 in cigarette smoke-induced emphysema. Am. J. Respir. Crit. Care Med.183, 876–884 (2011). ArticleCASPubMed Google Scholar
Russell, R. E. et al. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am. J. Respir. Cell. Mol. Biol.26, 602–609 (2002). ArticleCASPubMed Google Scholar
Russell, R. E. et al. Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases. Am. J. Physiol. Lung Cell. Mol. Physiol.283, L867–L873 (2002). ArticleCASPubMed Google Scholar
Vignola, A. M. et al. Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am. J. Respir. Crit. Care Med.158, 1945–1950 (1998). ArticleCASPubMed Google Scholar
Nozawa, H., Chiu, C. & Hanahan, D. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc. Natl Acad. Sci. USA103, 12493–12498 (2006). ArticleCASPubMedPubMed Central Google Scholar
Bergers, G. et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nature Cell Biol.2, 737–744 (2000). ArticleCASPubMed Google Scholar
Coussens, L. M., Tinkle, C. L., Hanahan, D. & Werb, Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell103, 481–490 (2000). ArticleCASPubMedPubMed Central Google Scholar
Itoh, T. et al. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res.58, 1048–1051 (1998). CASPubMed Google Scholar
Gupta, G. P. et al. Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature446, 765–770 (2007). ArticleCASPubMed Google Scholar
Lu, X. et al. ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. Genes Dev.23, 1882–1894 (2009). ArticleCASPubMedPubMed Central Google Scholar
D'Armiento, J., Dalal, S. S., Okada, Y., Berg, R. A. & Chada, K. Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema. Cell71, 955–961 (1992). ArticleCASPubMed Google Scholar
Joos, L. et al. The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum. Mol. Genet.11, 569–576 (2002). ArticleCASPubMed Google Scholar
Hautamaki, R. D., Kobayashi, D. K., Senior, R. M. & Shapiro, S. D. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science277, 2002–2004 (1997). This was the first study to combine cigarette smoke exposure and gene-targeted mice, which is now commonplace. It was also the first study to demonstrate a key role for MMP12 in cigarette smoke-induced emphysema. ArticleCASPubMed Google Scholar
Acuff, H. B. et al. Analysis of host- and tumor-derived proteinases using a custom dual species microarray reveals a protective role for stromal matrix metalloproteinase-12 in non-small cell lung cancer. Cancer Res.66, 7968–7975 (2006). ArticleCASPubMed Google Scholar
Houghton, A. M. et al. Macrophage elastase (matrix metalloproteinase-12) suppresses growth of lung metastases. Cancer Res.66, 6149–6155 (2006). ArticleCASPubMed Google Scholar
Cornelius, L. A. et al. Matrix metalloproteinases generate angiostatin: effects on neovascularization. J. Immunol.161, 6845–6852 (1998). CASPubMed Google Scholar
Kuhn, C., Yu, S. Y., Chraplyvy, M., Linder, H. E. & Senior, R. M. The induction of emphysema with elastase. II. Changes in connective tissue. Lab Invest.34, 372–380 (1976). CASPubMed Google Scholar
Shapiro, S. D. et al. Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice. Am. J. Pathol.163, 2329–2335 (2003). ArticleCASPubMedPubMed Central Google Scholar
Houghton, A. M. et al. Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nature Med.16, 219–223 (2010). ArticleCASPubMed Google Scholar
Foekens, J. A. et al. The prognostic value of polymorphonuclear leukocyte elastase in patients with primary breast cancer. Cancer Res.63, 337–341 (2003). CASPubMed Google Scholar
Akizuki, M. et al. Prognostic significance of immunoreactive neutrophil elastase in human breast cancer: long-term follow-up results in 313 patients. Neoplasia9, 260–264 (2007). ArticlePubMedPubMed Central Google Scholar
Houghton, A. M. et al. Elastin fragments drive disease progression in a murine model of emphysema. J. Clin. Invest.116, 753–759 (2006). ArticleCASPubMedPubMed Central Google Scholar
Mydel, P. et al. Neutrophil elastase cleaves laminin-332 (laminin-5) generating peptides that are chemotactic for neutrophils. J. Biol. Chem.283, 9513–9522 (2008). ArticleCASPubMedPubMed Central Google Scholar
Weathington, N. M. et al. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nature Med.12, 317–323 (2006). Seminal study demonstrating the importance of matrix fragments (independently of cytokines and chemokines) on the recruitment and maintenance of inflammatory cell infiltrates in the setting of lung injury. ArticleCASPubMed Google Scholar
Aberle, D. R. et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N. Engl. J. Med.365, 395–409 (2011). This study reports the results of a large, multi-centre, randomized, placebo-controlled clinical trial, which demonstrated a 20% reduction in lung cancer mortality from the use of chest CT screening. ArticlePubMed Google Scholar
Tammemagi, C. M. et al. Lung cancer risk prediction: prostate, lung, colorectal and ovarian cancer screening trial models and validation. J. Natl Cancer Inst.103, 1058–1068 (2011). ArticlePubMedPubMed Central Google Scholar
Parimon, T. et al. Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med.175, 712–719 (2007). ArticleCASPubMed Google Scholar
Calverley, P. M. et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N. Engl. J. Med.356, 775–789 (2007). ArticleCASPubMed Google Scholar
Stolina, M. et al. Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis. J. Immunol.164, 361–370 (2000). ArticleCASPubMed Google Scholar
Khuri, F. R. et al. Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. Clin. Cancer Res.7, 861–867 (2001). CASPubMed Google Scholar
Greenhough, A. et al. The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis30, 377–386 (2009). ArticleCASPubMed Google Scholar
Mao, J. T. et al. Lung cancer chemoprevention with celecoxib in former smokers. Cancer Prev. Res.4, 984–993 (2011). ArticleCAS Google Scholar
Solomon, S. D. et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N. Engl. J. Med.352, 1071–1080 (2005). ArticleCASPubMed Google Scholar
Heasley, L. E. et al. Induction of cytosolic phospholipase A2 by oncogenic Ras in human non-small cell lung cancer. J. Biol. Chem.272, 14501–14504 (1997). ArticleCASPubMed Google Scholar
Keith, R. L. et al. Pulmonary prostacyclin synthase overexpression chemoprevents tobacco smoke lung carcinogenesis in mice. Cancer Res.64, 5897–5904 (2004). ArticleCASPubMed Google Scholar
Keith, R. L. et al. Oral iloprost improves endobronchial dysplasia in former smokers. Cancer Prev. Res.4, 793–802 (2011). ArticleCAS Google Scholar
Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann. Intern. Med.93, 391–398 (1980).
Ito, K. et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N. Engl. J. Med.352, 1967–1976 (2005). ArticleCASPubMed Google Scholar
Adcock, I. M., Chung, K. F., Caramori, G. & Ito, K. Kinase inhibitors and airway inflammation. Eur. J. Pharmacol.533, 118–132 (2006). ArticleCASPubMed Google Scholar
Shepherd, F. A. et al. Erlotinib in previously treated non-small-cell lung cancer. N. Engl. J. Med.353, 123–132 (2005). ArticleCASPubMed Google Scholar
Soda, M. et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature448, 561–566 (2007). ArticleCASPubMed Google Scholar
Woodruff, P. G. et al. Safety and efficacy of an inhaled epidermal growth factor receptor inhibitor (BIBW 2948 BS) in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med.181, 438–445 (2010). ArticleCASPubMed Google Scholar
Hammerman, P. S. et al. Comprehensive genomic characterization of squamous cell lung cancers. Nature489, 519–525 (2012). ArticleCAS Google Scholar
Witschi, H. et al. The carcinogenicity of environmental tobacco smoke. Carcinogenesis18, 575–586 (1997). ArticleCASPubMed Google Scholar
Hubbard, R., Venn, A., Lewis, S. & Britton, J. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am. J. Respir. Crit. Care Med.161, 5–8 (2000). ArticleCASPubMed Google Scholar
Sandford, A. J., Weir, T. D., Spinelli, J. J. & Pare, P. D. Z and S mutations of the α1-antitrypsin gene and the risk of chronic obstructive pulmonary disease. Am. J. Respir. Cell. Mol. Biol.20, 287–291 (1999). ArticleCASPubMed Google Scholar
Yang, P. et al. α1-antitrypsin deficiency allele carriers among lung cancer patients. Cancer Epidemiol. Biomarkers Prev.8, 461–465 (1999). CASPubMed Google Scholar
Zhu, Y., Spitz, M. R., Lei, L., Mills, G. B. & Wu, X. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res.61, 7825–7829 (2001). CASPubMed Google Scholar
Cheng, S. L., Yu, C. J. & Yang, P. C. Genetic polymorphisms of cytochrome p450 and matrix metalloproteinase in chronic obstructive pulmonary disease. Biochem. Genet.47, 591–601 (2009). ArticleCASPubMed Google Scholar
Dialyna, I. A., Miyakis, S., Georgatou, N. & Spandidos, D. A. Genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes and lung cancer risk. Oncol. Rep.10, 1829–1835 (2003). CASPubMed Google Scholar
Xiao, D. et al. Relationship between polymorphisms of genes encoding microsomal epoxide hydrolase and glutathione S-transferase P1 and chronic obstructive pulmonary disease. Chin. Med. J.117, 661–667 (2004). CASPubMed Google Scholar
Park, J. Y., Chen, L., Wadhwa, N. & Tockman, M. S. Polymorphisms for microsomal epoxide hydrolase and genetic susceptibility to COPD. Int. J. Mol. Med.15, 443–448 (2005). CASPubMed Google Scholar
Benhamou, S., Reinikainen, M., Bouchardy, C., Dayer, P. & Hirvonen, A. Association between lung cancer and microsomal epoxide hydrolase genotypes. Cancer Res.58, 5291–5293 (1998). CASPubMed Google Scholar
Kao, R. C., Wehner, N. G., Skubitz, K. M., Gray, B. H. & Hoidal, J. R. Proteinase 3. A distinct human polymorphonuclear leukocyte proteinase that produces emphysema in hamsters. J. Clin. Invest.82, 1963–1973 (1988). ArticleCASPubMedPubMed Central Google Scholar
Zheng, T. et al. Role of cathepsin S-dependent epithelial cell apoptosis in IFN-γ-induced alveolar remodeling and pulmonary emphysema. J. Immunol.174, 8106–8115 (2005). ArticleCASPubMed Google Scholar
Yang, Y. et al. Cathepsin S mediates gastric cancer cell migration and invasion via a putative network of metastasis-associated proteins. J. Proteome Res.9, 4767–4778 (2010). ArticleCASPubMed Google Scholar
Brooks, P. C. et al. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin α v β 3. Cell85, 683–693 (1996). ArticleCASPubMed Google Scholar
Balbin, M. et al. Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nature Genet.35, 252–257 (2003). ArticleCASPubMed Google Scholar
Kudo, Y. et al. Matrix Metalloproteinase-13 (MMP-13) Directly and indirectly promotes tumor angiogenesis. J. Biol. Chem.287, 38716–38728 (2012). ArticleCASPubMedPubMed Central Google Scholar
Deshmukh, H. S. et al. Matrix metalloproteinase-14 mediates a phenotypic shift in the airways to increase mucin production. Am. J. Respir. Crit. Care Med.180, 834–845 (2009). ArticleCASPubMedPubMed Central Google Scholar
Hotary, K., Li, X. Y., Allen, E., Stevens, S. L. & Weiss, S. J. A cancer cell metalloprotease triad regulates the basement membrane transmigration program. Genes Dev.20, 2673–2686 (2006). ArticleCASPubMedPubMed Central Google Scholar